Inventor · disambiguated record
Lisardo Alvarez Fernandez
Also filed as: ALVAREZ FERNANDEZ LISARDO
14 granted patents·13 pending applications·8 citations·filing 2015–2024
85Inventor score
Files withSYNTHON BV27
Top patents by PatentIndex Score
27 records- 0187US10328028B2Pharmaceutical composition comprising amorphous lenalidomide and an antioxidantSYNTHON BV·Filed 2018·Granted Jun 25, 2019·3 cites·12 claims
- 0280US11007152B2Pharmaceutical composition comprising amorphous lenalidomide and an antioxidantSYNTHON BV·Filed 2019·Granted May 18, 2021·1 cites·3 claims
- 0375US10588892B2Pharmaceutical composition comprising sacubitril and valsartanSYNTHON BV·Filed 2018·Granted Mar 17, 2020·1 cites·21 claims
- 0475US10543174B2Modified release tablet composition comprising mirabegronSYNTHON BV·Filed 2017·Granted Jan 28, 2020·1 cites·16 claims
- 0574US10688050B1Pharmaceutical composition comprising ibrutinibSYNTHON BV·Filed 2018·Granted Jun 23, 2020·2 cites·17 claims
- 0671US2024350416A1Pharmaceutical composition comprising enzalutamideSYNTHON BV·Filed 2024·Application pending·0 cites
- 0763US2025352556A1Budesonide two layers capsule formulationSYNTHON BV·Filed 2023·Application pending·0 cites
- 0861US2025144100A1Pharmaceutical composition comprising ibrutinibSYNTHON BV·Filed 2022·Application pending·0 cites
- 0960US12409165B2Pharmaceutical composition comprising eltrombopag bis(monoethanolamine)SYNTHON BV·Filed 2020·Granted Sep 9, 2025·0 cites·17 claims
- 1060US2025381189A1Prolonged release tofacitinib compositions without functional coatingSYNTHON BV·Filed 2023·Application pending·0 cites
- 1160US2025134841A1Pharmaceutical composition of bempedoic acidSYNTHON BV·Filed 2022·Application pending·0 cites
- 1258US11911509B2Pharmaceutical composition comprising Lenvatinib mesylateSYNTHON BV·Filed 2018·Granted Feb 27, 2024·0 cites·17 claims
- 1358US11529353B2Pharmaceutical composition comprising PalbociclibSYNTHON BV·Filed 2018·Granted Dec 20, 2022·0 cites·20 claims
- 1457US12102630B2Crystalline forms and processes of lenvatinib besylateSYNTHON BV·Filed 2019·Granted Oct 1, 2024·0 cites·26 claims
- 1556US2022347102A1Pharmaceutical composition comprising enzalutamideSYNTHON BV·Filed 2020·Application pending·0 cites
- 1655US2023320990A1Pharmaceutical composition comprising ibrutinibSYNTHON BV·Filed 2021·Application pending·0 cites
- 1755US2024285633A1Prolonged release tofacitinib compositionsSYNTHON BV·Filed 2022·Application pending·0 cites
- 1852US2023025286A1Pharmaceutical composition comprising eltrombopag bis(monoethanolamine)SYNTHON BV·Filed 2020·Application pending·0 cites
- 1951US2022401446A1Controlled release tofacitinib compositionsSYNTHON BV·Filed 2020·Application pending·0 cites
- 2050US11517536B2Pharmaceutical composition comprising pomalidomideSYNTHON BV·Filed 2017·Granted Dec 6, 2022·0 cites·12 claims
- 2149US10507204B2Pharmaceutical composition comprising amorphous lenalidomideSYNTHON BV·Filed 2015·Granted Dec 17, 2019·0 cites·11 claims
- 2247US12290601B2Pharmaceutical composition comprising axitinibSYNTHON BV·Filed 2020·Granted May 6, 2025·0 cites·8 claims
- 2347US11865215B2Tablet compositions comprising abiraterone acetateSYNTHON BV·Filed 2019·Granted Jan 9, 2024·0 cites·20 claims
- 2446US2021220286A1Pharmaceutical composition comprising amorphous sunitinibSYNTHON BV·Filed 2019·Application pending·0 cites
- 2541US2019307696A1Tablets comprising mirabegron and solifenacinSYNTHON BV·Filed 2017·Application pending·0 cites
- 2636US2018000827A1Pharmaceutical composition comprising gefitinibSYNTHON BV·Filed 2015·Application pending·0 cites
- 2733US10471156B2Pharmaceutical composition comprising amorphous lenalidomideSYNTHON BV·Filed 2015·Granted Nov 12, 2019·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →